MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery

NCT06815289 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Primary Lung Cancer or Secondary Lung Metastases

Interventions

RADIATION: MR-informed stereotactic radiotherapy

Sponsor

University of Zurich